| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Peter Behner is Director at INKT. Peter Behner's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $263K at current prices.
Peter Behner has 20 Form 4 filings on record from March 2022 to September 2026, all as Director at MiNK Therapeutics (INKT), 2022–2026.
The 21 reported transactions were 17 stock awards and 4 option or other derivative awards.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria